Home
Intertek Pharmaceutical Services logo
Intertek Pharmaceutical Services

Intertek Pharmaceutical Services

1.5K
97
30
4.8(80)

About Company

  • Legal Name: Intertek Pharmaceutical Services
  • Registered country: United Kingdom
  • Address: 33 Cavendish Square London W1G 0PS
  • Number of employees: 1000 - 4999
Description:

Intertek pharmaceutical contract laboratory services, regulatory guidance and supply chain assurance brings quality and safety to life to support your unique pharmaceutical or biopharmaceutical outsourcing requirements. Our pharmaceutical scientists and regulatory experts work with you at every stage of development, providing consistently high quality and flexible services that enable you to achieve a marketplace advantage. Over the last 20 years, our network of Good Laboratory Practice (GLP), Good Clinical Practice (GCP) or Good Manufacturing Practice (cGMP) laboratories and regulatory experts have provided high quality technical services.

Business Activities

Biopharmaceutical Products

ManufacturerService ProviderConsultantContract ManufacturerPackaging SupplierTesting LaboratoryClinical Trial OrganizationEquipment Supplier

Biopharmaceutical Services

ManufacturerService ProviderConsultantContract ManufacturerPackaging SupplierTesting LaboratoryClinical Trial OrganizationEquipment Supplier

Laboratory & Analytical Services

ManufacturerService ProviderConsultantContract ManufacturerPackaging SupplierTesting LaboratoryClinical Trial OrganizationEquipment Supplier

ATC (Anatomical Therapeutic Chemical) Classification

ManufacturerService ProviderConsultantContract ManufacturerPackaging SupplierTesting LaboratoryClinical Trial OrganizationEquipment Supplier

Contract & Outsourcing Services

Service Provider

Contract Research Organisations Services (CROs)

Service Provider
Sales Markets
Key Products/Services

Our Products & Services

Certifications

Other

FDA

GMP

ISO

Proofs

CPHI Milan 2026
CPHI Milan 2026
10/2026 – 10/2026

CPHI Milan 2026

Location
Fiera Milano, Italy
Filters:
Sort by:

    No comments available.